Total Payments
$20,219
2024 Payments
$755.07
Companies
38
Transactions
201
Medicare Patients
2,314
Medicare Billing
$219,215
Payment Breakdown by Category
Other$15,850 (78.4%)
Food & Beverage$4,136 (20.5%)
Consulting$150.00 (0.7%)
Travel$75.21 (0.4%)
Education$7.98 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,850 | 5 | 78.4% |
| Food and Beverage | $4,136 | 193 | 20.5% |
| Consulting Fee | $150.00 | 1 | 0.7% |
| Travel and Lodging | $75.21 | 1 | 0.4% |
| Education | $7.98 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $16,586 | 43 | $0 (2023) |
| ABBVIE INC. | $540.73 | 34 | $0 (2024) |
| Biogen, Inc. | $396.57 | 17 | $0 (2021) |
| Amgen Inc. | $364.37 | 5 | $0 (2021) |
| PFIZER INC. | $284.26 | 24 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $271.09 | 6 | $0 (2024) |
| Genentech USA, Inc. | $162.81 | 9 | $0 (2024) |
| LivaNova USA, Inc. | $148.20 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $135.25 | 2 | $0 (2023) |
| Lundbeck LLC | $124.38 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $755.07 | 48 | ABBVIE INC. ($183.72) |
| 2023 | $670.37 | 29 | AstraZeneca Pharmaceuticals LP ($135.25) |
| 2022 | $328.12 | 28 | ABBVIE INC. ($130.78) |
| 2021 | $360.52 | 13 | Amgen Inc. ($129.89) |
| 2020 | $90.63 | 1 | E.R. Squibb & Sons, L.L.C. ($90.63) |
| 2019 | $198.67 | 6 | Amgen Inc. ($125.00) |
| 2018 | $12,041 | 38 | ACADIA Pharmaceuticals Inc ($11,460) |
| 2017 | $5,775 | 38 | ACADIA Pharmaceuticals Inc ($4,966) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: PAIN | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.09 | General |
| Category: PAIN | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/29/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: VACCINE | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.35 | General |
| Category: NEUROLOGY | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: PAIN | ||||||
| 10/03/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: NEUROLOGY | ||||||
| 10/01/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Neuroscience | ||||||
| 09/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: PAIN | ||||||
| 08/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Central Nervous System | ||||||
| 08/20/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: DIABETES | ||||||
| 08/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Rare Disease | ||||||
| 07/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Neuropsychiatry | ||||||
| 06/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.28 | General |
| Category: NEUROLOGY | ||||||
| 05/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 508 | 616 | $192,509 | $52,763 |
| 2022 | 12 | 468 | 536 | $193,829 | $44,243 |
| 2021 | 15 | 662 | 796 | $261,240 | $61,985 |
| 2020 | 16 | 676 | 803 | $265,862 | $60,224 |
Total Patients
2,314
Total Services
2,751
Medicare Billing
$219,215
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 56 | 98 | $21,954 | $8,782 | 40.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 54 | $30,950 | $8,680 | 28.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 64 | 65 | $27,357 | $8,292 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $22,773 | $5,841 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 67 | $20,421 | $5,778 | 28.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 62 | $11,988 | $3,753 | 31.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 70 | 73 | $18,535 | $3,130 | 16.9% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 23 | 25 | $8,003 | $2,188 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 21 | $4,335 | $1,309 | 30.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 20 | 37 | $5,317 | $1,246 | 23.4% |
| 95717 | Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report | Facility | 2023 | 13 | 16 | $3,838 | $1,232 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 15 | $5,671 | $1,118 | 19.7% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 22 | 24 | $8,279 | $992.22 | 12.0% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2023 | 11 | 11 | $3,088 | $421.81 | 13.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 68 | $29,285 | $9,914 | 33.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 54 | 57 | $34,159 | $9,229 | 27.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 65 | 78 | $15,875 | $4,033 | 25.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 44 | $11,178 | $3,388 | 30.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 75 | 77 | $34,496 | $3,182 | 9.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 34 | 34 | $10,504 | $3,130 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 29 | $7,356 | $2,690 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $7,549 | $2,680 | 35.5% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2022 | 27 | 36 | $23,606 | $1,558 | 6.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 26 | 47 | $7,521 | $1,488 | 19.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 11 | $5,266 | $1,249 | 23.7% |
About Fahed Saada
Fahed Saada is a Neurology healthcare provider based in East Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1316223613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Fahed Saada has received a total of $20,219 in payments from pharmaceutical and medical device companies, with $755.07 received in 2024. These payments were reported across 201 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,850).
As a Medicare-enrolled provider, Saada has provided services to 2,314 Medicare beneficiaries, totaling 2,751 services with total Medicare billing of $219,215. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location East Syracuse, NY
- Active Since 10/31/2011
- Last Updated 08/22/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1316223613
Products in Payments
- NUPLAZID (Drug) $16,586
- Aimovig (Biological) $254.89
- UBRELVY (Drug) $212.69
- COPAXONE (Drug) $204.30
- ELIQUIS (Drug) $179.54
- QULIPTA (Drug) $159.99
- ZINBRYTA (Biological) $150.00
- NURTEC ODT (Drug) $139.48
- TECFIDERA (Drug) $133.29
- VNS Therapy (Device) $131.51
- NUEDEXTA (Drug) $113.70
- TYSABRI (Biological) $112.15
- ANDEXXA (Biological) $109.60
- VYEPTI (Biological) $107.10
- Ocrevus (Biological) $84.67
- OCREVUS (Biological) $78.14
- ACTHAR (Biological) $78.10
- XARELTO (Drug) $62.16
- Nourianz (Drug) $58.32
- BOTOX (Biological) $52.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.